1. Home
  2. ENVX vs WGS Comparison

ENVX vs WGS Comparison

Compare ENVX & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enovix Corporation

ENVX

Enovix Corporation

HOLD

Current Price

$6.93

Market Cap

1.4B

Sector

Miscellaneous

ML Signal

HOLD

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

HOLD

Current Price

$39.26

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENVX
WGS
Founded
2006
2017
Country
United States
United States
Employees
N/A
1300
Industry
Industrial Machinery/Components
Retail: Computer Software & Peripheral Equipment
Sector
Miscellaneous
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
ENVX
WGS
Price
$6.93
$39.26
Analyst Decision
Buy
Strong Buy
Analyst Count
9
7
Target Price
$13.61
$120.71
AVG Volume (30 Days)
5.2M
1.4M
Earning Date
05-13-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
40.94
N/A
EPS
N/A
N/A
Revenue
$31,821,000.00
N/A
Revenue This Year
$30.37
$29.98
Revenue Next Year
$238.73
$25.92
P/E Ratio
N/A
$1,251.58
Revenue Growth
37.91
N/A
52 Week Low
$4.67
$32.21
52 Week High
$16.49
$170.87

Technical Indicators

Market Signals
Indicator
ENVX
WGS
Relative Strength Index (RSI) 58.91 30.39
Support Level $6.68 N/A
Resistance Level $8.66 $96.34
Average True Range (ATR) 0.44 3.84
MACD -0.00 -2.34
Stochastic Oscillator 61.94 18.78

Price Performance

Historical Comparison
ENVX
WGS

About ENVX Enovix Corporation

Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, the United States, Norway, Taiwan, and other regions.

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Share on Social Networks: